Skip to main content
. 2022 Oct 18;9:1008683. doi: 10.3389/fmed.2022.1008683

Table 4.

New TCMs approved in mainland China from 2016 to 2021.

Number Approval number Product name Approval date
1 Z20160001 Jinhua Qinggan Granules 2016/9/2
2 Z20170001 Danlong oral liquid 2017/8/24
3 Z20180001 Guanhuangmu granule 2018/2/2
4 Z20180002 Jinrong granule 2018/12/25
5 Z20191000 Total coumarins from Fructus Cnidii 2019/3/4
6 Z20191001 Fructus Cnidii total coumarin ointment 2019/3/4
7 Z20194049 Lishi Huayu suppository 2019/5/9
8 Z20190021 Xiao'er Jingxing Zhike granule 2019/12/16
9 Z20190022 Shaoma Zhijing granule 2019/12/18
10 Z20200001 Mulberry Twig Alkaloid 2020/3/17
11 Z20200002 Mulberry Twig Alkaloid Tablet 2020/3/17
12 Z20200003 Jingu Zhitong gel 2020/4/9
13 Z20200004 Lianhuaqingke Tablets 2020/5/12
14 C20210001 Qingfei Paidu granule 2021/3/2
15 C20210002 Huashi Baidu granule 2021/3/2
16 C20210003 Xuanfei Baidu granule 2021/3/2
17 Z20210001 Yishen Yangxin Anshen tablet 2021/9/1
18 Z20210002 Yiqi Tongqiao pill 2021/9/13
19 Z20210003 Yinqiao Qingre tablet 2021/11/9
20 Z20210004 Xuanqijiangu tablet 2021/11/24
21 Z20210005 Qizhi Yishen Capsule 2021/11/24
22 Z20210008 Jieyu Chufan capsule 2021/11/24
23 Z20210006 Kunxinning granule 2021/11/24
24 Z20210007 Huzhen Qingfeng capsule 2021/12/14
25 Z20210009 Qiruiweishu capsule 2021/12/31

Z20191000 and Z20200001 are crude drugs.